Target intelligence / Profile preview

Multiple cell types and tissue microenvironment (TME)

Target
TME
Molecular classification
Other
01

Overview

The 'Multiple cell types and tissue microenvironment' refers to the integrated network of cells, signaling molecules, and the extracellular matrix (ECM) that surrounds a specific cell type within a tissue (Source: NIH, National Cancer Institute). This entity is not a singular molecular target but rather a multifaceted biological system or niche that governs cell behavior, development, and disease progression. In oncology, the tumor microenvironment (TME) is particularly critical, as it includes immune cells, fibroblasts, and endothelial cells that can be co-opted to support tumor survival and immune evasion (Source: PubMed, PMID: 32029530). While individual molecules within this environment—such as PD-1 or VEGF—are targeted by drugs like Nivolumab or Bevacizumab, the environment as a whole represents a landscape of interactions rather than a single druggable protein (Source: PubMed, PMID: 28659478). Consequently, this classification is often used to describe the broader context of therapeutic action rather than a specific molecular receptor or enzyme.

Other names
Tumor microenvironmentTissue microenvironmentCellular nicheStromaExtracellular matrix and associated cells
02

Mechanism of action

Modulation of specific cellular components (e.g., immune checkpoint inhibition), disruption of extracellular matrix signaling, or inhibition of pro-angiogenic factors within the tissue niche.

03

Biological functions

Cell-cell communicationSignal transductionImmune responseCell proliferationHomeostasisAngiogenesis
04

Disease associations

CancerInflammationFibrosisAutoimmune diseaseInfection
05

Safety considerations

Off-target effects in non-diseased tissue environmentsImmune-related adverse events (irAEs)Systemic toxicity due to broad environmental modulationDifficulty in modeling complex human environments in preclinical studies
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Programmed death-ligand 1 (PD-L1) expressionTumor-infiltrating lymphocytes (TILs)Cancer-associated fibroblast (CAF) markersExtracellular matrix densityTumor mutational burden (TMB)

Beyond the preview

Go deeper on Multiple cell types and tissue microenvironment (TME).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cell types and tissue microenvironment (TME).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call